ARIS HiQ Instrument
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Place of performance: MD
Free. Verify your email, then we send one reminder only.
- Posted
- Sep 2, 2026
- Closes
- No deadline published by the funder
Similar opportunities open now
- Notice of Intent to Award a Sole Source - iLab Solutions Subscription Renewal for CCR Core FacilitiesSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- ASIT.TO 1 year software support from ArgonSoft (Notice of Intent to sole source)Same funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses in 64 days
- VC-Vitek Mass Spectrometer PrimeOpenDEPT OF DEFENSENo deadline listed
- Purchase of Biacore T200 Surface Plasmon Resonance Service Plan.Same funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Notice of Intent to Award Sole Source – Imaris License RenewalSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
At a glance
This is a government contract opportunity posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in the in-vitro diagnostic substance manufacturing category. Work is performed in MD.
Classification and identifiers
- Industry (NAICS)
- In-Vitro Diagnostic Substance Manufacturing (325413)
- Product or service (PSC)
- Drugs and Biologicals (6505)
- Solicitation number
- 26-007626
- Contracting office
- NATIONAL INSTITUTES OF HEALTH OLAO
Who can apply
About this opportunity
The National Institute of Health (NIH) intends to negotiate and award a purchase order without providing for full and open competition to REMEL, INC. The purpose of this requirement is to provide a firm-fixed-price contract for the Remel ARIS HiQ Instrument and associated SWIN Computer System in the Department of Laboratory Medicine (DLM). The purpose of this acquisition is to establish a follow-on reagent rental agreement with Remel, Inc. for the ARIS HiQ Instrument and associated SWIN Computer System utilized by the Department of Laboratory Medicine (DLM), Microbiology Service, to perform antimicrobial susceptibility testing (AST). The agreement will provide continued access to the existing instrumentation, susceptibility testing panels, reagents, consumables, supplies, software support,...